Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.

@article{Stoddard2014DetectionOA,
  title={Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.},
  author={Robyn A. Stoddard and Conrad P Quinn and Jarad Schiffer and Anne E. Boyer and Jason M Goldstein and Dennis A. Bagarozzi and Stephen D Soroka and Leslie A. Dauphin and Alex R. Hoffmaster},
  journal={Journal of immunological methods},
  year={2014},
  volume={408},
  pages={
          78-88
        }
}

Figures and Tables from this paper

High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures
TLDR
A method was developed for LTx-specific quantification in plasma using anti-PA IgG magnetic immunoprecipitation of PA and quantification of LF activity that co-purified with PA, demonstrating the importance of LTx as a diagnostic and therapeutic target.
Production and Purification of Protective Antigen of Bacillus anthracis and Development of a Sandwich ELISA for its Detection
TLDR
PYS5 plasmid containing the full PA gene was transformed into an 8 proteases deficient Bacillus anthracis host BH480 and purified using the gel filtration chromatography for development of a sandwich ELISA for detection of PA.
Rapid Capsular Antigen Immunoassay for Diagnosis of Inhalational Anthrax: Preclinical Studies and Evaluation in a Nonhuman Primate Model
TLDR
A rapid lateral flow immunoassay that detects capsular antigen of Bacillus anthracis that is shed into blood during infection that can be performed at the point of patient contact, is rapid and inexpensive, and can be used by individuals with minimal training.
Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R
TLDR
A sandwich ELISA and cytotoxicity-based method for quantitative detection of PA and LF is developed and found that LT proteins expressed by the A16R and Sterne strains were found to be monomeric and showed cytotoxic activity, which may be the main reason for side effects of live anthrax vaccines.
Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.
TLDR
This study is the first to report circulating PA83 in inhalation anthrax, typically at less than 4% of the levels of PA63, providing the first evidence that activated PA63 is the primary form of PA throughout infection.
In vivo dynamics of active edema and lethal factors during anthrax
TLDR
In this study, the in vivo kinetics of production of the toxin components EF (edema factor) and LF (lethal factor) during cutaneous infection with a wild-type toxinogenic encapsulated strain in immuno-competent mice are unraveled for the first time.
Phage Display Analysis of Monoclonal Antibody Binding to Anthrax Toxin Lethal Factor
TLDR
The activation effects of these mAbs contribute to the analytic sensitivity of function-based LF detection assays.
Anthrax in injecting drug users: the need for increased vigilance in the clinic
The emergence of a previously unrecognized route of Bacillus anthracis infection over the last few years has led to concern: sporadic anthrax outbreaks among heroin users in northern Europe have
...
1
2
...

References

SHOWING 1-10 OF 28 REFERENCES
Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered Immunoassays
TLDR
Simple anthrax toxin detection ELISAs could prove useful in the evaluation of potential therapies and possibly as a clinical diagnostic to complement other strategies for the rapid identification of B. anthracis infection.
Protective Antigen as a Correlative Marker for Anthrax in Animal Models
TLDR
It is demonstrated that the presence and level of a bacterial antigen, the protective antigen (PA), a component of B. anthracis toxins, in host sera can serve as a reliable marker of infection.
Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles
TLDR
The results indicate that the universal labeling technology based on europium nanoparticles and its application may provide a rapid and sensitive testing platform for clinical diagnosis and laboratory research.
Lethal Factor Toxemia and Anti-Protective Antigen Antibody Activity in Naturally Acquired Cutaneous Anthrax
TLDR
This is the first report of quantitative analysis of serum LF in cutaneous anthrax and the first to associate acute stage toxemia with subsequent antitoxin antibody responses.
Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen
TLDR
The Centers for Disease Control and Prevention developed, optimized, and rapidly qualified an enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G (IgG) antibodies to Bacillus anthracis protective antigen (PA) in human serum that proved valuable for the confirmation of cases of cutaneous and inhalational anthrax and evaluation of patients in whom the diagnosis of anthrax was being considered.
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
TLDR
Anti-PA IgG is an important diagnostic marker of anthrax, a predictor of serum anti-toxin activity, and a marker of immunological memory against anthrax.
Identification of a Surrogate Marker for Infection in the African Green Monkey Model of Inhalation Anthrax
TLDR
The ECL immunoassay described here is simple and sensitive enough to provide results in one to two hours, making this assay a viable option for use in the diagnosis of anthrax, leading to timely initiation of treatment, which is a key component of B. anthracis therapeutic development.
Detection and quantification of anthrax lethal factor in serum by mass spectrometry.
TLDR
This method represents a highly specific and rapid diagnostic tool for early anthrax and has a potential additional role as a research tool for understanding toxemia and effects of medical countermeasures for anthrax.
Anthrax Protective Antigen Cleavage and Clearance from the Blood of Mice and Rats
TLDR
The cell binding-independent cleavage of PA was verified by using Ub-PA to rescue mice from toxin challenge by competitively binding circulating LF and it was shown that lethality of LF for mice after PA was no longer measurable in circulation, suggesting active PA sequestration at tissue surfaces.
...
1
2
3
...